Melatonin restores Muc2 depletion induced by V. vulnificus VvpM via melatonin receptor 2 coupling with Gαq.

J Biomed Sci

Department of Pharmaceutical Engineering, Daegu Haany University, Hanuidae-ro 1, BioCenter, Suite 709, Gyeongsan-si, Gyeongsangbuk-do, 38610, South Korea.

Published: January 2020

AI Article Synopsis

  • Melatonin plays a critical role in preserving Muc2 production in the intestines during bacterial infections, specifically in response to the Gram-negative bacterium V. vulnificus.
  • The study showed that melatonin treatment significantly counteracted the reduction of Muc2 in human intestinal cells induced by a recombinant protein from the bacteria, linking its effects to melatonin receptor 2 and the inhibition of reactive oxygen species.
  • In mouse models, melatonin not only maintained Muc2 levels during V. vulnificus infection but also had effects similar to a mutation of the bacterial gene responsible for toxin production, indicating its protective role against intestinal mucin repression.

Article Abstract

Background: Melatonin (5-methoxy-N-acetyltryptamine), a hormone produced in the pineal gland, has a variety of biological functions as an antioxidant, but a functional role of melatonin in the regulation of intestinal mucin (Muc) production during bacterial infection has yet to be described in detail. In this study, we investigate the effects of melatonin during Muc2 repression elicited by the Gram-negative bacterium V. vulnificus.

Methods: Mucus-secreting human HT29-MTX cells were used to study the functional role of melatonin during Muc2 depletion induced by the recombinant protein (r) VvpM produced by V. vulnificus. The regulatory effects of melatonin coupling with melatonin receptor 2 (MT) on the production of reactive oxygen species (ROS), the activation of PKCδ and ERK, and the hypermethylation of the Muc2 promoter as induced by rVvpM were examined. Experimental mouse models of V. vulnificus infection were used to study the role of melatonin and how it neutralizes the bacterial toxin activity related to Muc2 repression.

Results: Recombinant protein (r) VvpM significantly reduced the level of Muc2 in HT29-MTX cells. The repression of Muc2 induced by rVvpM was significantly restored upon a treatment with melatonin (1 μM), which had been inhibited by the knockdown of MT coupling with Gαq and the NADPH oxidase subunit p47 . Melatonin inhibited the ROS-mediated phosphorylation of PKCδ and ERK responsible for region-specific hypermethylation in the Muc2 promoter in rVvpM-treated HT29-MTX cells. In the mouse models of V. vulnificus infection, treatment with melatonin maintained the level of Muc2 expression in the intestine. In addition, the mutation of the VvpM gene from V. vulnificus exhibited an effect similar to that of melatonin.

Conclusions: These results demonstrate that melatonin acting on MT inhibits the hypermethylation of the Muc2 promoter to restore the level of Muc2 production in intestinal epithelial cells infected with V. vulnificus.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6943958PMC
http://dx.doi.org/10.1186/s12929-019-0606-xDOI Listing

Publication Analysis

Top Keywords

melatonin
13
role melatonin
12
ht29-mtx cells
12
hypermethylation muc2
12
muc2 promoter
12
level muc2
12
muc2
11
muc2 depletion
8
depletion induced
8
melatonin receptor
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!